SCHEMBL24299592

SCHEMBL24299592

Nc1ccc(N2CCC(CO)CC2)nn1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ PDE10A Q9Y233 9/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ PDE2A O00408 2/20 0.38
▸ PDE1B Q01064 2/20 0.38
▸ PDE4D Q08499 2/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CDK6 Q00534 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ MAP4K4 O95819 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KLF5 Q13887 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PDE11A Q9HCR9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30790717 1.00 PIK3CA (0.40) PIK3CAMTORPDE10ALMNAHTT
SCHEMBL20037726 0.83 MAP4K4 (0.39) PIK3CAMTORPDE10AMAP4K4KMT2A
SCHEMBL9195108 0.82 PDE10A (0.44) PIK3CAMTORPDE10ALMNAHTT
SCHEMBL20255203 0.81 PDE10A (0.40) PDE10ALMNAHTTPDE2APDE1B
SCHEMBL9198277 0.81 LMNA (0.61) PDE10ALMNAHTTMEN1KMT2A
SCHEMBL16880317 0.80 JAK2 (0.38) LMNAHTTNPC1RAB9AKLF5
SCHEMBL30349708 0.79 LMNA (0.43) LMNAHTTMEN1KMT2ASMN1; SMN2
SCHEMBL458210 0.78 PDE10A (0.39) PIK3CAMTORPDE10ALMNAHTT
SCHEMBL9219556 0.78 HRH3 (0.50) PDE10ALMNAHTTPDE2APDE1B
SCHEMBL12832968 0.78 NPC1 (0.56) LMNAHTTNPC1RAB9AKLF5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048605-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATIONS 南昌奥瑞药业有限公司 2022-03-10 — — WO disclosed
Send feedback